Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Closed Incision NPWT to Prevent Wound Complications Post-ECMO

NCT: NCT07709546 · NOT_YET_RECRUITING

NCT IDNCT07709546
StatusNOT_YET_RECRUITING
Start Date2026-07-13
Completion2029-03-18
SponsorSt. Antonius Hospital (OTHER)
First posted
Last updated

Brief Summary

Patients undergoing extracorporeal membrane oxygenation (ECMO) are at increased risk of wound complications at the vascular access site after decannulation. These complications may delay recovery and increase healthcare burden. Closed incision negative pressure wound therapy (NPWT) may improve wound healing by reducing fluid accumulation and supporting the incision. This study evaluates whether prophylactic NPWT reduces wound complications compared to standard wound care following ECMO decannulation.

Frequently Asked Questions

What is Closed Incision NPWT to Prevent Wound Complications Post-ECMO?

Closed Incision NPWT to Prevent Wound Complications Post-ECMO is a clinical trial registered under NCT07709546. Current status: NOT_YET_RECRUITING.

What is the status of NCT07709546?

The current status of NCT07709546 (Closed Incision NPWT to Prevent Wound Complications Post-ECMO) is: NOT_YET_RECRUITING.

When did Closed Incision NPWT to Prevent Wound Complications Post-ECMO start?

Closed Incision NPWT to Prevent Wound Complications Post-ECMO started on 2026-07-13.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.